Issue 2/1997
Content (11 Articles)
TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expression
K.D. Amoils, W.R. Bezwoda
Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells
Rosella Silvestrini, Daniela Gornati, Nadia Zaffaroni, Alessandra Bearzatto, Cinzia De Marco
Macromolecular interstitial clearance, tumour vascularity, other prognostic factors and breast cancer survival
Ernest E. Sterns, Sandip SenGupta, Benny Zee
Inhibition of hormone and growth factor responsive and resistant human breast cancer cells by CeReS-18, a cell regulatory sialoglycopeptide
Heideh K. Fattaey, Natalie A. Betz, Brenda A. Westhoff, Philip J. Moos, Terry C. Johnson
CeReS-18, a novel cell surface sialoglycopeptide, induces cell cycle arrest and apoptosis in a calcium-sensitive manner
Natalie A. Betz, Heideh K Fattaey, Brenda A. Westhoff, Avelina Q. Paulsen, Terry C. Johnson
Validation of existing and development of new prognostic classification schemes in node negative breast cancer
Willi Sauerbrei, Klaus Hübner, Claudia Schmoor, Martin Schumacher
Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma
Peter B. Vermeulen, Martha Libura, Jolantha Libura, Patrick J. O‘Neill, Peter van Dam, Eric Van Marck, Allan T. Van Oosterom, Luc Y. Dirix
Clinical significance of bcl-2 gene expression in human breast cancer tissues
Shunzo Kobayashi, Hirotaka Iwase, Yukashi Ito, Hiroko Yamashita, Hiroji Iwata, Toshinari Yamashita, Kazuko Ito, Tatsuya Toyama, Takaaki Nakamura, Akira Masaoka
Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer
P. Pronzato, P. Queirolo, M. Landucci, F. Vaira, A. Vigani, M. Gipponi, F. Cafiero
Seasonal trends in the self-detection of breast cancer: indications from the Cancer and Steroid Hormone (CASH) study
Julie A. Ross, Richard K. Severson, Scott Davis, Janet L. Stanford, John D. Potter